BaseSpace
Correlation
Engine-Public
Sign In
Register
Correlation Engine 2.0
Home
My Data
Bookmarks
Collaborations
Inbox
Import Your Data
QuickView
FAQ
What is QuickView?
What can my QuickView results tell me?
What are the sources for the General Info tab in QuickView?
More QuickView FAQs
Back to top
QuickView
Curated
Studies
Body
Atlas
Disease
Atlas
Pharmaco
Atlas
Knockdown
Atlas
Genetic
Markers
Pathway
Enrichment
Literature
Clinical
Trials
0
Meta-
Analysis
QuickView
Search sequence regions
(e.g.
Stem cell
,
Amniocentesis
,
Tamoxifen
,
rs2230926
,
SNCA
,
nitric oxide metabolic process
)
Organisms
Chromosomes
Start
Stop
Homo Sapiens
Mus Musculus
Rattus Norvegicus
C. Elegans
D. Melanogaster
Saccharomyces Cerevisiae
QuickView
Go back to main search
Bookmark
Forward
QuickView
for
FDA
Summary
General Info
Curated Studies
Most Correlated Studies
B-cell lymphoma cell lines treated by 92 FDA approved compounds - a timecourse
Hippocampi of fingolimod-treated mice after fear consolidation test
Breast cancer cells with siRNA against ING2 or treated with 2uM HDAC inhibitor SAHA
Multiple myeloma LP-1 cells resistant to proteasome inhibitor carfilzomib
Glioblastoma stem cells treated with mibefradil
Explore Curated Studies Results
Literature
Most Relevant Literature
FDA OK's HIF2α Inhibitor Belzutifan.
Applications of promiscuity of FDA-approved kinase inhibitors in drug repositioning and toxicity.
The FDA and the COVID-19: A political economy perspective.
Awareness and beliefs about FDA e-cigarette regulation in the premarket application review era.
Properties of FDA-approved small molecule protein kinase inhibitors: A 2023 update.
Explore Literature Results
Clinical Trials
Most Relevant Clinical Trials
Meta-analysis of 46 FDA Identified Studies on Lipid Markers
Study of Incidence of Respiratory Tract AEs in Patients Treated With Tyvaso® Compared to Other FDA A…
Clinical Investigation of Omega Refractive Capsule Model V With Use of an FDA Approved IOL
Performance Comparison of a New Fetal/Maternal Monitor With an FDA-cleared Method
FDA "Breakthrough Drugs": A Trial Testing the Effect of Alternative Language on Public Perceptions
Explore Clinical Trials Results
search
→
result
search
→
result
See more about this page
See complete FAQ